The potentiating effect of platelet on plasminogen activation by tissue plasminogen activator.
A new role for platelets in fibrinolysis is proposed. Platelets (euglobulin from platelet rich plasma and from human platelet extract) may potentiate plasminogen activation by tissue plasminogen activator (tPA). The potentiating activity was detected by both chromogenic substrate and fibrin plate analysis. The fibrinolysis-potentiating substance in the platelets required the presence of both tPA and plasminogen, suggesting that it potentiates the activation of plasminogen by tPA. This substance was not related to fibrinogen degradation products because it was also present in platelets from two afibrinogenemic patients and did not lose its activity when separated from fibrinogen-related antigen by Sepharose 2B gel filtration. Since platelets contain both activator(s) and inhibitor(s) of plasminogen activation by tPA, a balance between activator(s) and inhibitor(s) in platelets may also be required for control of the fibrinolytic pathway.
D000936:Antigen-Antibody Complex; D001792:Blood Platelets / Q000502:physiology*; D004789:Enzyme Activation; D005337:Fibrin / Q000502:physiology; D005342:Fibrinolysis; D006801:Humans; D005779:Immunodiffusion; D007700:Kinetics; D010958:Plasminogen / Q000502:physiology*; D012016:Reference Values; D012712:Serum Globulins / Q000502:physiology; D013927:Thrombosis / Q000097:blood; D010959:Tissue Plasminogen Activator / Q000502:physiology*
D000936:Antigen-Antibody Complex; D012712:Serum Globulins; D005337:Fibrin; D010958:Plasminogen; D010959:Tissue Plasminogen Activator